Lindbrook Capital’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$221K Buy
3,991
+154
+4% +$8.34K 0.02% 385
2024
Q4
$185K Sell
3,837
-214
-5% -$10.9K 0.02% 399
2024
Q3
$233K Sell
4,051
-337
-8% -$18.2K 0.02% 360
2024
Q2
$213K Buy
4,388
+351
+9% +$16.9K 0.02% 347
2024
Q1
$196K Sell
4,037
-169
-4% -$8.25K 0.02% 363
2023
Q4
$209K Sell
4,206
-951
-18% -$46.5K 0.02% 338
2023
Q3
$277K Buy
5,157
+1,136
+28% +$60.6K 0.03% 256
2023
Q2
$217K Buy
4,021
+215
+6% +$11.6K 0.02% 311
2023
Q1
$207K Buy
3,806
+122
+3% +$5.93K 0.02% 304
2022
Q4
$178K Sell
3,684
-263
-7% -$11.5K 0.02% 352
2022
Q3
$150K Buy
3,947
+20
+0.5% +$891 0.03% 334
2022
Q2
$196K Buy
3,927
+680
+21% +$36.1K 0.03% 288
2022
Q1
$167K Sell
3,247
-550
-14% -$28.4K 0.03% 332
2021
Q4
$190K Buy
3,797
+72
+2% +$3.56K 0.03% 320
2021
Q3
$180K Sell
3,725
-30
-0.8% -$1.52K 0.05% 172
2021
Q2
$198K Buy
3,755
+46
+1% +$2.4K 0.04% 169
2021
Q1
$183K Buy
3,709
+252
+7% +$12.1K 0.04% 167
2020
Q4
$168K Sell
3,457
-28
-0.8% -$1.38K 0.04% 162
2020
Q3
$175K Sell
3,485
-26
-0.7% -$1.34K 0.05% 138
2020
Q2
$179K Buy
3,511
+185
+6% +$8.99K 0.05% 133
2020
Q1
$145K Sell
3,326
-1,002
-23% -$47.9K 0.05% 136
2019
Q4
$217K Buy
4,328
+272
+7% +$12.7K 0.08% 132
2019
Q3
$188K Sell
4,056
-257
-6% -$11.1K 0.07% 142
2019
Q2
$186K Buy
4,313
+686
+19% +$29.2K 0.07% 140
2019
Q1
$160K Sell
3,627
-610
-14% -$26.1K 0.06% 157
2018
Q4
$183K Buy
+4,237
New +$187K 0.09% 120

Other funds holding SNY

Lindbrook Capital's SNY Position: Q1 2025 in Review

Lindbrook Capital increased its Sanofi (SNY) stake by 4% in Q1 2025, buying an estimated $8.34K and bringing the position to 3,991 shares worth $221K. The position accounts for 0.02% of the portfolio, ranked #385.

Lindbrook Capital first reported a position in SNY in Q4 2018 and has held it in 26 quarters since. The position peaked at $277K in Q3 2023. 773 funds tracked by Wall St. Rank hold SNY as of Q1 2025.

  • Lindbrook Capital held 3,991 shares of Sanofi worth $221K as of Q1 2025.
  • Lindbrook Capital bought 154 Sanofi shares in Q1 2025, an estimated $8.34K.
  • Sanofi made up 0.02% of Lindbrook Capital's portfolio in Q1 2025, its #385 holding.
  • Lindbrook Capital first reported a position in Sanofi in Q4 2018 and has held it in 26 quarters since.
  • Lindbrook Capital's Sanofi position peaked at $277K in Q3 2023.
  • 773 funds tracked by Wall St. Rank held Sanofi as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.